scispace - formally typeset
L

Leila R. Martins

Researcher at Instituto de Medicina Molecular

Publications -  20
Citations -  1247

Leila R. Martins is an academic researcher from Instituto de Medicina Molecular. The author has contributed to research in topics: Leukemia & PI3K/AKT/mTOR pathway. The author has an hindex of 13, co-authored 17 publications receiving 1128 citations. Previous affiliations of Leila R. Martins include German Cancer Research Center & University of Lisbon.

Papers
More filters
Journal ArticleDOI

Aberrant signaling in T-cell acute lymphoblastic leukemia: biological and therapeutic implications

TL;DR: This review focused on how deregulation of critical signaling pathways, in particular Notch, PI3K/Akt, MAPK, Jak/STAT and TGF-beta, may contribute to T-ALL.
Journal ArticleDOI

On CK2 regulation of chronic lymphocytic leukemia cell viability

TL;DR: It is shown that inhibition of CK2 induces apoptosis of CLL cells, whereas it does not significantly impact normal lymphocytes, demonstrating the selectivity of the CK2 inhibitors toward leukemia cells.
Journal ArticleDOI

Surfactant Expression Defines an Inflamed Subtype of Lung Adenocarcinoma Brain Metastases that Correlates with Prolonged Survival.

TL;DR: The expression of surfactant metabolism-related genes (SFTPA1, SFTPB, and NAPSA) defines an inflamed subtype of lung adenocarcinoma brain metastases characterized by high abundance of TILs in close vicinity to tumor cells, a prolonged survival, and a tumor microenvironment which might be more accessible to immunotherapeutic approaches.
Journal ArticleDOI

Stk33 is required for spermatid differentiation and male fertility in mice.

TL;DR: It is reported that the serine/threonine kinase Stk33 is essential for the differentiation of round spermatids into functional sperm cells and male fertility and targeted deletion of StK33 in these cells recapitulates the defects observed in constitutive knockout mice, confirming a germ cell-intrinsic function.